123 related articles for article (PubMed ID: 25785489)
1. Steroidal 5α-Reductase Inhibitors: A Comparative 3D-QSAR Study Review.
Thareja S
Chem Rev; 2015 Apr; 115(8):2883-94. PubMed ID: 25785489
[No Abstract] [Full Text] [Related]
2. Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids.
Thareja S; Rajpoot T; Verma SK
Steroids; 2015 Mar; 95():96-103. PubMed ID: 25582615
[TBL] [Abstract][Full Text] [Related]
3. A review on steroidal 5α-reductase inhibitors for treatment of benign prostatic hyperplasia.
Sun J; Xiang H; Yang LL; Chen JB
Curr Med Chem; 2011; 18(23):3576-89. PubMed ID: 21756226
[TBL] [Abstract][Full Text] [Related]
4. Mechanism based representation of the active site of 5 alpha-reductase (5AR).
Ahmed S; Denison S
Bioorg Med Chem Lett; 1998 Sep; 8(18):2615-70. PubMed ID: 9873591
[TBL] [Abstract][Full Text] [Related]
5. Determination of rat 5alpha-reductase type 1 isozyme activity and its inhibition by novel steroidal oxazolines.
Szécsi M; Ondré D; Tóth I; Magony S; Wölfling J; Schneider G; Julesz J
Acta Biol Hung; 2010 Sep; 61(3):274-81. PubMed ID: 20724274
[TBL] [Abstract][Full Text] [Related]
6. Re: 5α-Reductase Type 1 Modulates Insulin Sensitivity in Men.
Kaplan SA
J Urol; 2015 Sep; 194(3):736-7. PubMed ID: 26292878
[No Abstract] [Full Text] [Related]
7. Dutasteride affects progesterone metabolizing enzyme activity/expression in human breast cell lines resulting in suppression of cell proliferation and detachment.
Wiebe JP; Souter L; Zhang G
J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):129-40. PubMed ID: 16806904
[TBL] [Abstract][Full Text] [Related]
8. Novel and Predictive QSAR Model for Steroidal and Nonsteroidal 5α- Reductase Type II Inhibitors.
Mando H; Hassan A; Gharaghani S
Curr Drug Discov Technol; 2021; 18(2):317-332. PubMed ID: 32208118
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors.
Karnsomwan W; Netcharoensirisuk P; Rungrotmongkol T; De-Eknamkul W; Chamni S
Chem Pharm Bull (Tokyo); 2017; 65(3):253-260. PubMed ID: 28250347
[TBL] [Abstract][Full Text] [Related]
10. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.
Cabeza M; Sánchez-Márquez A; Garrido M; Silva A; Bratoeff E
Curr Med Chem; 2016; 23(8):792-815. PubMed ID: 26861003
[TBL] [Abstract][Full Text] [Related]
11. QSAR studies on human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroids.
Aggarwal S; Thareja S; Verma A; Bhardwaj TR; Kumar M
Acta Pol Pharm; 2011; 68(3):447-52. PubMed ID: 21648201
[No Abstract] [Full Text] [Related]
12. Linear relationships between the ligand binding energy and the activation energy of time-dependent inhibition of steroid 5alpha-reductase by delta 1-4-azasteroids.
Tian G; Haffner CD
J Biol Chem; 2001 Jun; 276(24):21359-64. PubMed ID: 11279132
[TBL] [Abstract][Full Text] [Related]
13. 3D-QSAR studies on unsaturated 4-azasteroids as human 5alpha-reductase inhibitors: a self organizing molecular field analysis approach.
Aggarwal S; Thareja S; Bhardwaj TR; Kumar M
Eur J Med Chem; 2010 Feb; 45(2):476-81. PubMed ID: 19906465
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel hybrid from finasteride and epristeride as 5α-reductase inhibitor.
Yao Z; Xu Y; Zhang M; Jiang S; Nicklaus MC; Liao C
Bioorg Med Chem Lett; 2011 Jan; 21(1):475-8. PubMed ID: 21094046
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro effect of novel 4,16-pregnadiene-6,20-dione derivatives, as 5alpha-reductase inhibitors.
Bratoeff E; Cabeza M; Pérez-Ornelas V; Recillas S; Heuze I
J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):275-81. PubMed ID: 18644453
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the 5alpha-reductase-3alpha-hydroxysteroid dehydrogenase complex in the human brain.
Steckelbroeck S; Watzka M; Reichelt R; Hans VH; Stoffel-Wagner B; Heidrich DD; Schramm J; Bidlingmaier F; Klingmüller D
J Clin Endocrinol Metab; 2001 Mar; 86(3):1324-31. PubMed ID: 11238528
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and 5α-reductase inhibitory activity of C₂₁ steroids having 1,4-diene or 4,6-diene 20-ones and 4-azasteroid 20-oximes.
Kim S; Kim YU; Ma E
Molecules; 2011 Dec; 17(1):355-68. PubMed ID: 22210173
[TBL] [Abstract][Full Text] [Related]
18. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1.
Issa S; Schnabel D; Feix M; Wolf L; Schaefer HE; Russell DW; Schweikert HU
J Clin Endocrinol Metab; 2002 Dec; 87(12):5401-7. PubMed ID: 12466325
[TBL] [Abstract][Full Text] [Related]
19. Biological activities of a new steroidal inhibitor of delta 4-5 alpha-reductase.
Brooks JR; Berman C; Hichens M; Primka RL; Reynolds GF; Rasmusson GH
Proc Soc Exp Biol Med; 1982 Jan; 169(1):67-73. PubMed ID: 7063497
[No Abstract] [Full Text] [Related]
20. Synthesis and characterization of 3β-substituted amides of 17a-aza-D-homo- 4-androsten-17-one as potent 5α-reductase inhibitors and antimicrobial agents.
Malhotra M; Sharma R; Rawal RK; Heer H; Bhardwaj TR
Curr Top Med Chem; 2013 Aug; 13(16):2047-61. PubMed ID: 23895091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
